510(k) device
VICTUS Femtosecond Laser Platform
Technolas Perfect Vision GmbH · Ophthalmic Femtosecond Laser (OOE, Class II) · First FDA decision Jul 31, 2012, newest Sep 1, 2020Cataract
Last checked: Nov 20, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
8
510(k) pathway
Device trials
5
Naming "VICTUS"
MAUDE reports
1
Brand "VICTUS", since 2015
PubMed studies
45
Mentioning "VICTUS"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing VICTUS Femtosecond Laser Platform
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology, with pictures of the device
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 6 of 8 decisions filed under this name.
K200724 · Decided Sep 1, 2020 · 166 days after receipt
Device type: Ophthalmic Femtosecond Laser (OOE) · Ophthalmology
5 more FDA decisions with a free account
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
No Medicare coverage document has a title matching this device or device type. Many devices are paid under existing codes without one.
Clinical trials
Device studies on ClinicalTrials.gov that name "VICTUS", any status and sponsor, newest update first.
Technolas Perfect Vision GmbHNot on our public-company list
NCT01693211 · 48 participants · Start Sep 2012 · Primary completion Jun 2014
Device: Femtosecond Laser (VICTUS™ Femtosecond Laser Platform); Manual (CCC technique with Utrata forceps) · For: Primary Disease: Cataract
Sites: Singapore, Singapore
4 more trials with a free account
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "VICTUS", and for the whole product code for context.
This brand
1 reports: 0 malfunction, 1 injury, 0 death
Whole product code OOE
4,559 reports: 2,002 malfunction, 2,527 injury, 0 death
Newest reports for this brand
3003691824-2026-00001 · Received Sep 22, 2026 · Event dated Aug 13, 2026
Device type: Ophthalmic Femtosecond Laser (OOE)
Device problem as coded: Adverse Event Without Identified Device or Use Problem
Patient problem as coded: Capsular Bag Tear
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "VICTUS"[tiab]. The summary above synthesizes these.
- Intraocular pressure rises during laser in situ keratomileusis: Comparison of 3 femtosecond laser platforms.
Bolivar G, Garcia-Gonzalez M, Laucirika G, et al. · J Cataract Refract Surg · 2019Comparative Study
- Electron microscopy of laser capsulotomy edge: Interplatform comparison.
Bala C, Xia Y, Meades K · J Cataract Refract Surg · 2014Comparative Study
- Effects of Femtosecond Laser-Assisted Cataract Pretreatment on Pupil Diameter: A Comparison Between Three Laser Platforms.
Diakonis VF, Yesilirmak N, Sayed-Ahmed IO, et al. · J Refract Surg · 2016Comparative Study
- Femtosecond Laser-Assisted Big-Bubble Deep Anterior Lamellar Keratoplasty.
Pedrotti E, Bonacci E, De Rossi A, et al. · Clin Ophthalmol · 2021
- Laser-integrated real-time OCT in anterior segment procedures.
Neuhann R, Neuhann T, Hörster R, et al. · J Cataract Refract Surg · 2021
- Femtosecond Laser-Assisted Capsulotomy: Histological Comparison of Four Different Laser Platforms.
Hengerer FH, Mittelbronn M, Hansmann ML, et al. · J Refract Surg · 2017Comparative Study
- [The first experience of using femtosecond laser in the treatment of anterior capsular contraction syndrome].
Yusef YN, Yusef SN, Vvedenskiy AS, et al. · Vestn Oftalmol · 2024English Abstract
- Randomized Controlled Trial Comparing Femtosecond Laser-Assisted with Conventional Phacoemulsification on Dense Cataracts.
Chee SP, Yang Y, Wong MHY · Am J Ophthalmol · 2021Randomized Controlled Trial, Research Support, Non-U.S. Gov't
- Corneal incision architecture: VICTUS femtosecond laser vs manual keratome.
Rodrigues R, Santos MSD, Silver RE, et al. · Clin Ophthalmol · 2019
- Femtosecond laser-assisted cataract surgery for the white cataract.
Chee SP, Chan NS, Yang Y, et al. · Br J Ophthalmol · 2019Observational Study, Video-Audio Media
- Meniscus-Shaped Stromal Lenticule Addition Keratoplasty for Corneal Regularization and Thickening in Advanced Keratoconus.
Pedrotti E, Bonacci E, Fasolo A, et al. · Cornea · 2023
- FLACS (Femtosecond-Laser-Assisted Cataract Surgery) combined with pupiloplasty in iris-lens coloboma.
Castilla-Martinez G, Fernandez-Martinez C, Pardo-Lopez S, et al. · Am J Ophthalmol Case Rep · 2024Case Reports
Other devices of this type
Also filed under product code OOE.
- LENSAR Laser System - fs 3D (LLS-fs 3D)Lensar, Inc. · 510(k) 2018
- LenSx Laser System (8065000944)Alcon Laboratories, Inc. · 510(k) 2025
- Catalys Precision Laser SystemAmo Manufacturing USA, LLC · 510(k) 2023
- Catalys Precision Laser SystemOptimedica Corporation · 510(k) 2016
- TbdLensar, Inc. · 510(k) 2013
- Lensx 550 Laser System. Model 550Lensx Lasers, Inc. · 510(k) 2010
- FEMTO LDV Z8 Femtosecond Surgical LaserSie Ag,Surgical Instrument Engineering · 510(k) 2022
- ELITA Femtosecond Laser System, ELITA Patient InterfaceJohnson & Johnson Surgical Vision, Inc. · 510(k) 2023
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.